[Federal Register: November 22, 2004 (Volume 69, Number 224)]
[Notices]               
[Page 67947]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22no04-103]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--National Council for Prescription Drug Programs

    Notice is hereby given that, on September 14, 2004, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), National Council for 
Prescription Drug Programs (``NCPDP'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the name and principal place of business of 
the standards development organization and (2) the nature and scope of 
its standards development activities. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: National 
Council for Prescription Drug Programs, Scottsdale, AZ. The nature and 
scope of NCPDP's standards development activities are: Creating and 
promoting standards for the transfer for data to and from the pharmacy 
services sector of the healthcare industry.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 04-25863 Filed 11-19-04; 8:45 am]

BILLING CODE 4410-11-M